Literature DB >> 31094228

Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Wei-Ping Hu1, Tsokyi Lhamo1,2, Dong Liu3, Jing-Qing Hang4, Feng-Ying Zhang4, Yi-Hui Zuo1, Ying-Ying Zeng1, Jing Zhang1.   

Abstract

Acute exacerbation (AE) is the main cause of increased disability and mortality for patients with Chronic Obstructive Pulmonary Disease (COPD). Short-term re-exacerbation after discharge is common for in-hospital patients with AECOPD. Thus, we aimed to design a scoring system to effectively predict the 30-day re-exacerbation using simple and easily accessible variables. We retrospectively enrolled 686 cases hospitalized for AECOPD in two Chinese hospitals from 2005 to 2017. A variety of parameters were collected like demographics, clinical manifestations and treatments in stable and AE period. The optimal subset of covariates in the multivariate logistic analysis was identified by the smallest Akaike Information Criterion (AIC) and was further used to develop a practical and reliable nomogram to predict the 30-day re-exacerbation. The efficacy of the nomogram was internally validated by concordance index (C-index) and a calibration plot. The incidence of 30-day re-exacerbation was 15.8%. Based on the smallest AIC, eight easily-accessible parameters were included in the nomogram, including sex, COPD assessment test (CAT) scores, AE with respiratory failure in the previous year, new purulent sputum, new cardiovascular events, combined antibiotic therapy, theophylline therapy for AE and ICU admission. Our nomogram revealed good discriminative ability with the C-index of 0.702. The calibration curve showed good agreement between nomogram-predicted probability and actual observation. Incorporating eight common variables, a nomogram for 30-day re-exacerbation after discharge with high predictive performance was constructed for patients with AECOPD, which was helpful in predicting individualized risk of re-exacerbation and offering individualized post-discharge support.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; acute exacerbation; nomogram; re-exacerbation

Mesh:

Year:  2019        PMID: 31094228     DOI: 10.1080/15412555.2019.1606187

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  3 in total

1.  Effect of PIFR-based optimised inhalation therapy in patients recovering from acute exacerbation of chronic obstructive pulmonary disease: protocol of a prospective, multicentre, superiority, randomised controlled trial.

Authors:  Jianlan Hua; Wei Zhang; Hui-Fang Cao; Chun-Ling Du; Jia-Yun Ma; Yi-Hui Zuo; Jing Zhang
Journal:  BMJ Open       Date:  2020-05-07       Impact factor: 2.692

2.  Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses.

Authors:  Balázs Csoma; András Bikov; Ferenc Tóth; György Losonczy; Veronika Müller; Zsófia Lázár
Journal:  ERJ Open Res       Date:  2021-02-08

Review 3.  Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies.

Authors:  Wilhelmine H Meeraus; Bailey M DeBarmore; Hana Mullerova; William A Fahy; Victoria S Benson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.